Excipients used in pharmaceutical formulation and development are important. These substances contain ingredients besides the drug or prodrug that is pharmacologically active. Drug delivery to the target site is facilitated by pharmaceutical excipients. These molecules assimilate and improve the drug's effectiveness while preventing the drug from being released too early. Some excipients used in pharmaceuticals encourage drug integration, which increases drug absorption in the bloodstream. Pharmaceutical excipients are additionally used to identify drugs.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-pharmaceutical-excipients-market
Data Bridge Market Research analyses that the Pharmaceutical Excipients Market is expected to reach the value of USD 12,199.90 million by 2029, at a CAGR of 6.6% during the forecast period. The expanding pharmaceutical industry, driven by increasing global population, aging demographics, and rising healthcare needs, fuels the demand for pharmaceutical excipients as essential components in drug formulation.
Increase in generic drugs is expected to drive the market's growth rate
The increase in generic drug production, resulting from patent expirations and cost-saving initiatives, has led to a significant demand for pharmaceutical excipients. Generic drug manufacturers rely on excipients to develop cost-effective and safe formulations that are bioequivalent to their branded counterparts. Excipients play a crucial role in ensuring the stability, functionality, and overall quality of generic drugs, making them an essential component in the formulation process for these manufacturers.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Functionality (Binders And Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants,Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others).
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Kerry Group plc. (Ireland), DFE Pharma (Netherlands), Cargill, Incorporated (U.S.), Pfanstiehl (U.S.), Colorcon (U.S.), MEGGLE GmbH & Co. KG (Germany), Omya AG (Switzerland), Peter Greven GmbH & Co. KG (Germany), Ashland (U.S.), Evonik (Germany), Dow (U.S.), Croda International Plc (U.K.), Roquette Frères (France), The Lubrizol Corporation (U.S.), BASF SE (Germany), Avantor, Inc. (U.S.), BENEO (Germany), Chemie Trade (Germany) among others
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The pharmaceutical excipients market is segmented on the basis of functionality, dosage forms, route of administration, end user, and distribution channel.
- On the basis of functionality, the global pharmaceutical excipients market is segmented into binders and adhesives, disintegrants, coating material, coloring agents, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidents, chelating agents, antifoaming agents, and others. In 2022, the binders and adhesives segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 9.8% in the forecast period of 2022 to 2029 due to low active dose tablets. Commonly used in wet granulation, binders are added to create a more effective and predictable granule formulation.
In 2021, the binders and adhesives segment is expected to dominate the functionality of the global pharmaceutical excipients market.
In 2021, the binders and adhesives segment is expected to dominate the global pharmaceutical excipients market owing to essential for tablet formulations to hold the ingredients together. Coating materials are used to provide a protective layer and improve the appearance of tablets. Disintegrants aid in the breakdown of tablets or capsules for faster drug release. Diluents are used as fillers to increase the bulk of tablets or capsules with a CAGR of 9.8% in the forecast period of 2022 to 2029.
- On the basis of dosage form, the global pharmaceutical excipients market is segmented into solid, semi-solid, and liquid. Solid segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 6.8% in the forecast period of 2022 to 2029 due to most pharmaceutical excipients are used to manufacture solid dosage forms. Active pharmaceutical ingredient (API) is used to manufacture solid dosage forms in low quantities. So, pharmaceutical excipients are used to improve stability and increase the volume of the dosage form.
- On the basis of route of administration, the global pharmaceutical excipients market is segmented into oral excipients, topical excipients, parenteral excipients, and other excipients. Oral excipients segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.1% in the forecast period of 2022 to 2029 due to therapy, are available in the oral form with the highest effectiveness, enhanced bioavailability, and strong onset of action.
- On the basis of end user, the global pharmaceutical excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organizations and academics, and others. The pharmaceutical and biopharmaceutical companies segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.0% in the forecast period of 2022 to 2029 due to market since most pharmaceutical excipients used in these companies are responsible for producing medicines in all dosage forms, such as solid, semi-solid, and liquid. Pharmaceutical excipients are used in the manufacturing of these dosage forms of medicines.
In 2022, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the end user segment of the global pharmaceutical excipients market
In 2022, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the global pharmaceutical excipients market owing to companies rely on advanced research and innovative technologies to discover and manufacture drugs for the treatment of various conditions, including interstitial cystitis (IC) with a CAGR of 7.0% in the forecast period of 2022 to 2029.
- On the basis of distribution channels, the global pharmaceutical excipients market is segmented into direct tender, retail sales, and others. In 2022, the direct tender segment is expected to dominate the global pharmaceutical excipients market with a CAGR of 7.0% in the forecast period of 2022 to 2029 due to the primary distribution source of pharmaceutical excipients. Hence, the market players deal directly with pharmaceutical excipients for further manufacturing.
Major Players
Data Bridge Market Research는 제약 부형제 시장의 주요 기업으로 Kerry Group plc.(아일랜드), DFE Pharma(네덜란드), Cargill, Incorporated(미국), Pfanstiehl(미국), Colorcon(미국), MEGGLE GmbH & Co. KG(독일), Omya AG(스위스), Peter Greven GmbH & Co. KG(독일), Ashland(미국), Evonik(독일)을 꼽았습니다.
시장 개발
- 2022년, 세계 최대의 맛과 영양 기업인 케리 그룹(Kerry Group Plc.)은 두 개의 대형 생명공학 기업을 인수하여 지식, 기술 포트폴리오, 제조 역량을 확장했다고 밝혔습니다.
- 2022년, CD Formulation은 생체이용률이 높은 부형제를 위한 맞춤형 솔루션을 출시하여 약물 개발의 오랜 문제인 생체이용률 저하 문제를 해결했습니다.
- 2022년, 인도 하이데라바드에서 의약품 및 건강기능식품용 부형제 솔루션 분야의 선두주자인 DFE Pharma가 최신 "제형업체에 더 가까이"(C2F) 우수 센터를 설립했습니다.
- 2021년, 제약용 부형제 솔루션 공급업체인 DFE Pharma가 BioHale이라는 새로운 제품군을 출시하여 생물제약 회사가 전 세계적으로 공급 문제를 해결할 수 있도록 지원했습니다.
- 2021년 Croda International Plc는 고성능 기술과 성분을 개발한다는 목표로 Genesis Biosciences와 파트너십을 맺었습니다.
- 2021년, Roquette는 채식주의자용 소프트 젤 캡슐을 제조하기 위한 바로 사용 가능한 제약 등급 솔루션인 LYCAGEL Premix를 출시했습니다.
지역 분석
지리적으로, 제약용 부형제 시장 보고서에서 다루는 국가는 북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 남미의 일부인 기타 남미, 브라질, 아르헨티나입니다.
Data Bridge Market Research 분석에 따르면:
북미는 2022-2029년 예측 기간 동안 제약용 부형제 시장 에서 지배적인 지역입니다.
북미 지역은 연구 개발 투자 증가에 힘입어 세계 제약 부형제 시장에서 주도적인 역할을 하고 있습니다. 미국은 Evonik, Dow, Croda International Plc 등 주요 기업들의 탄탄한 입지를 바탕으로 이 지역에서 중요한 역할을 수행하고 있습니다. 이러한 기업들은 고품질 부형제를 끊임없이 혁신하고 개발함으로써 시장 성장에 기여하고 있으며, 제약 산업의 첨단 제형 솔루션에 대한 수요 증가에 대응하고 있습니다.
아시아 태평양 지역은 2022-2029년 예측 기간 동안 제약 첨가제 시장에서 가장 빠르게 성장하는 지역으로 추정됩니다.
중국은 아시아 태평양 지역 제약 부형제 시장에서 지배적인 위치를 차지하고 있습니다. 이는 중국 제약 산업의 급속한 성장과 제네릭 의약품 생산 증가에 기인합니다. 중국의 인구 증가, 의료 수요 증가, 그리고 저렴한 의료 서비스 제공을 위한 정부 정책은 제약 부형제 수요를 촉진했습니다. 중국 제조업체들은 증가하는 제네릭 의약품 수요를 충족하기 위해 비용 효율적인 부형제 생산에 집중하고 있으며, 이는 중국이 아시아 태평양 지역 제약 부형제 시장에서 우위를 점하는 데 기여하고 있습니다.
제약용 부형제 시장 보고서 에 대한 자세한 내용은 여기를 클릭하세요 - https://www.databridgemarketresearch.com/reports/global-pharmaceutical-excipients-market
